1. Home
  2. PTCT vs ORA Comparison

PTCT vs ORA Comparison

Compare PTCT & ORA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PTC Therapeutics Inc.

PTCT

PTC Therapeutics Inc.

HOLD

Current Price

$75.18

Market Cap

6.1B

Sector

Health Care

ML Signal

HOLD

Logo Ormat Technologies Inc.

ORA

Ormat Technologies Inc.

HOLD

Current Price

$125.85

Market Cap

7.0B

Sector

Utilities

ML Signal

HOLD

Company Overview

Basic Information
Metric
PTCT
ORA
Founded
1998
1965
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Electric Utilities: Central
Sector
Health Care
Utilities
Exchange
Nasdaq
Nasdaq
Market Cap
6.1B
7.0B
IPO Year
2013
2004

Fundamental Metrics

Financial Performance
Metric
PTCT
ORA
Price
$75.18
$125.85
Analyst Decision
Buy
Strong Buy
Analyst Count
17
8
Target Price
$73.76
$119.63
AVG Volume (30 Days)
1.2M
547.2K
Earning Date
02-26-2026
02-25-2026
Dividend Yield
N/A
0.39%
EPS Growth
N/A
11.26
EPS
8.94
2.18
Revenue
$1,779,150,000.00
$944,248,000.00
Revenue This Year
$129.80
$11.56
Revenue Next Year
N/A
$17.90
P/E Ratio
$8.53
$56.72
Revenue Growth
97.54
6.07
52 Week Low
$35.95
$61.58
52 Week High
$87.50
$125.35

Technical Indicators

Market Signals
Indicator
PTCT
ORA
Relative Strength Index (RSI) 47.95 69.60
Support Level $73.77 $115.35
Resistance Level $77.55 $125.35
Average True Range (ATR) 3.50 3.16
MACD -0.10 0.71
Stochastic Oscillator 53.42 95.21

Price Performance

Historical Comparison
PTCT
ORA

About PTCT PTC Therapeutics Inc.

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating segment: life science.

About ORA Ormat Technologies Inc.

Ormat Technologies Inc is engaged in the geothermal and recovered energy power business. It is engaged in three business segments: Electricity Segment. where the company develops, builds, owns and operates geothermal, solar PV and recovered energy-based power plants in the United States and geothermal power plants in other countries and sell the electricity generated. Product Segment includes designing, manufacturing and selling equipment for geothermal and recovered energy-based electricity generation and providing services relating to the engineering, procurement and construction of geothermal and recovered energy-based power plants. Energy Storage Segment includes owning and operating grid-connected which provide capacity, energy and ancillary services directly to the electric grid.

Share on Social Networks: